Showing results (531-540 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|October 21, 2024
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumorDror Limon, Alexandra Amiel, Shaked Even Haim, et al.
Neuro-Oncology Advances|September 5, 2024
Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A reviewJakub Jarmula, Juyeun Lee, Adam Lauko, et al.
Neuro-Oncology Advances|August 9, 2024
Glioblastoma vulnerability to neddylation inhibition is dependent on PTEN status, and dysregulation of the cell cycle and DNA replicationBrett Taylor, Nanyun Tang, Yue Hao, et al.
Neuro-Oncology Advances|September 2, 2024
Is pulsed saturation transfer sufficient for differentiating radiation necrosis from tumor progression in brain metastases?Rachel W Chan, Wilfred W Lam, Hanbo Chen, et al.
Neuro-Oncology Advances|July 18, 2024
An update on central nervous system tumors in germline replication-repair deficiency syndromesAnirban Das, Ayse Bahar Ercan, Uri Tabori
Neuro-Oncology Advances|July 24, 2024
Impact of intensity-modulated proton therapy in reducing radiation-induced lymphopenia in glioma patientsAnindita Das, Jacinthlyn Sylvia, Ganapathy Krishnan, et al.
Neuro-Oncology Advances|July 29, 2024
Beyond T2-FLAIR mismatch sign in isocitrate dehydrogenase mutant 1p19q non-codeleted astrocytoma: Analysis of tumor core and evolution with multiparametric magnetic resonance imagingJian Ping Jen, Xuanxuan Li, Markand Patel, et al.
Neuro-Oncology Advances|July 26, 2024
Cytotoxicity on low-grade canine meningioma with the use of somatostatin analog (octreotide): An in vitro studyMaria Teresa Mandara, Alessia Tognoloni, Giuseppe Giglia, et al.
Neuro-Oncology Advances|July 22, 2024
Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAFV600E glioblastoma results in sustained response: A case reportNaveed Wagle, Akanksha Sharma, Minhdan Nguyen, et al.
Neuro-Oncology Advances|July 22, 2024
Marrow-ablative consolidation chemotherapy and molecular targeted therapy delivered in a risk-adapted manner for newly diagnosed children with choroid plexus carcinoma: A work in progressMaxim Yankelevich, Wafik Zaky, Lucie Lafay-Cousin, et al.
Pageof 134